Discussion about this post

User's avatar
YOUR DOCTOR KLOVER's avatar

Helpful post! “Coconut oil for Alzheimer’s” sits right at the intersection of a real physiologic idea and a lot of overreach. The kernel of plausibility is metabolic: in some patients with AD or MCI there’s reduced cerebral glucose utilization, and ketones can serve as an alternative fuel. But coconut oil is a very blunt tool for that, its fatty acid profile is mostly saturated fat, and while it contains some MCTs, it’s not the same as a standardized MCT formulation used in trials. So the evidence for meaningful cognitive benefit is limited and inconsistent, and any potential upside needs to be weighed against cardiometabolic risk in the individual (LDL/apoB response can be substantial in some people). What I’d add for our longevity-focused readers is a practical, safety-first approach:

1. If someone wants to experiment, do it as a time-limited, trackable trial (sleep, function, cognition/behavior notes), and don’t let it displace the interventions with stronger evidence: vascular risk control, hearing/sleep optimization, exercise, and appropriate meds.

2. If there’s known dyslipidemia or high ASCVD risk, be cautious; consider MCT oil (in small doses) rather than large amounts of coconut oil, and monitor lipids.

3. And if symptoms are changing, prioritize a proper cognitive workup rather than chasing a single “superfood” answer.

Pete Field's avatar

Great write up and looking forward to the MCT article.

I know you didn't say "LDL should be as low as possible" but there are other benefits to LDL. Do you believe that we should be keeping cholesterol with the current guidelines? Or do you think that only applies when APO, immune impairment, or high iron suggest a risk of arterial plaques? Maybe another article idea for you.

7 more comments...

No posts

Ready for more?